Showing results (191-200 of 2,409) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 14, 2021
Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival statusAllyson Hart, Yoon Son Ahn, Crystal Watson, et al.Journal of Medical Economics|April 27, 2021
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare populationDeborah A Fisher, Jordan J Karlitz, Sushanth Jeyakumar, et al.Journal of Medical Economics|April 27, 2021
Burden of illness among Medicare and non-Medicare US populations with acquired thrombotic thrombocytopenic purpuraLaurence Pollissard, Anne Shah, Rajeshwari S Punekar, et al.Journal of Medical Economics|April 21, 2021
Is there a correlation between total fertility rate, utilization of assisted reproduction technology, and national wealth in Europe?Amir Lass, Geffen LassJournal of Medical Economics|April 21, 2021
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims databaseAlex Exuzides, Ning Wu, Daniel Sheinson, et al.Journal of Medical Economics|April 19, 2021
Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trialElizabeth A Magnuson, Haiyan Li, Katherine Vilain, et al.Journal of Medical Economics|April 19, 2021
Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson's disease patients treated with levodopa/carbidopaRyan N Hansen, Kangho Suh, Michael Serbin, et al.Journal of Medical Economics|April 16, 2021
Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United StatesDavid A Iannitti, Chong Kim, Diane Ito, et al.Journal of Medical Economics|May 17, 2012
The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsAnnie Guérin, Eric Q Wu, Vamsi K Bollu, et al.Journal of Medical Economics|April 13, 2012
Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomesJanneke Jentink, Cornelis Boersma, Lolkje T W de Jong-van den Berg, et al.Pageof 241